期刊文献+

某院427株鲍曼不动杆菌耐药及临床分布情况分析 被引量:3

Analysis of drug resistance and clinical distribution of 427 acinetobacter baumannii strains in a hospital
下载PDF
导出
摘要 目的:对该院2017-01~2018-12鲍曼不动杆菌的分布情况及耐药性特点进行分析,为医院防控管理、临床合理使用抗生素提供实验室依据。方法:通过VITEK-2配套试剂板及Walk Away40 Plus检测板进行菌种鉴定及药敏,按照最新CLSI标准进行比对。结果:共收集不重复菌株427株,临床科室分布以ICU和急诊ICU为主,标本类型以痰液标本为主。鲍曼不动杆菌对亚胺培南耐药率最高,为62.5%;对头孢他啶、头孢吡肟、环丙沙星、氨曲南耐药率>50%。结论:临床分离鲍曼不动杆菌以呼吸道标本为主,且耐药情况严重,以ICU感染最为严重,临床应规范抗生素的使用,加大临床感控监测力度。 Objective:To analyze the distribution of acinetobacter baumannii and its characteristics of drug re-sistance,so as to provide a laboratory basis for hospital control management and rational clinical use of antibiotics.Methods:The distribution and drug resistance characteristics of acinetobacter baumannii were analyzed from Janu-ary 2017 to December 2018 in the First Affiliated Hospital of Jiamusi University.Strain identification and drug sen-sitivity test were conducted through vitek-2 matching reagent board and Walk Away 40 Plus test board.Compari-son was conducted according to the latest CLSI standard.Results:A total of 427 non-repeating strains were col-lected.The clinical departments were mainly distributed in ICU and emergency ICU,and the specimens were main-ly sputum specimens.Acinetobacter baumannii had the highest drug resistance rate to imipenem(62.5%).The drug resistance rates to ceftazidime,cefepime,ciprofloxacin and aminotriannan were all greater than 50%.Conclu-sion:the clinical isolation of acinetobacter baumannii was dominated by respiratory specimens,and the drug resist-ance was serious,and the ICU infection was the most serious.We should standardize the use of antibiotics and strengthen the monitoring of clinical infection control.
作者 王瑶 席健峰 邹佳贺 王勇 WANG Yao;XI Jian-feng;ZOU Jia-he;WANG Yong(First Affiliated Hospital of Jiamusi University,Jiamusi 154003,China)
出处 《黑龙江医药科学》 2020年第3期44-45,36,共3页 Heilongjiang Medicine and Pharmacy
关键词 鲍曼不动杆菌 耐药性分析 临床分布 acinetobacter baumannii drug resistance analysis clinical distribution
  • 相关文献

参考文献13

二级参考文献115

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2童卫杭,王睿.不动杆菌属细菌对碳青霉烯类抗生素耐药机制及用药选择[J].中华医学杂志,2006,86(35):2516-2519. 被引量:11
  • 3Abraham EP,Chain E. An enzyme from bacteria able to destroy penieillin[J]. Rev Infect Dis, 1988,10(4) : 677-678.
  • 4Bush K, Fisher JF. Epidemiological Expansion, Structural Studies and Clinical Challenges of New l]dactamases from Gram-Negative Bacteria[J]. Annu Rev Microbiol, 2011,65 (1) : 455-478.
  • 5Lin YC, Hsia KC,Chen YC, et al. Genetic basis of multidrug re- sistance in Acinetobacter clinical isolates in Taiwan[J]. Antimicrob Agents Chemother, 2010,54 (5) : 2078-2084.
  • 6Ben RJ,Yang MC, Hsueh JC, et al. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in south- ern Taiwan[J]. Int J Antimicrob Agents, 2011,38 (5) : 403-408.
  • 7Potron A,Munoz-Price LS,Nordmann P,et al. Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti [J]. Antimicrob Agents Chemother, 2011,55 (12) : 5946-5948.
  • 8Jan Walther-Rasmussen, Niels Hoiby. OXA-type carbapenemases [J]. Journal of Antimicrobial Chemotherapy, 2006,57 (3) : 373- 383.
  • 9Amudhan SM, Sekar U, Arunagiri K, et al. OXA beta-lactamase- mediated carbapenem resistance in Acinetobacter baumannii[J]. Indian J Med Microbiol,2011,29(3) 269-274.
  • 10Verma V,Testero SA, Amini K. Hydrolytic mechanism of OXA- 58 enzyme, a earhapenem-hydrolyzing class D 13-1actamase from Acinetobacter baumannii[J]. J Biol Chem, 2011,286 (43) : 37292- 37303.

共引文献499

同被引文献32

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部